Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
408.6 DKK | +0.29% |
|
-2.62% | +10.19% |
05-10 | NOVONESIS : Key segments outperform in average Q1 24 showing | ![]() |
05-03 | Transcript : Novozymes A/S, Q1 2024 Sales/ Trading Statement Call, May 03, 2024 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.19% | 27.14B | |
+12.02% | 1.79B | |
-7.28% | 661M | |
-26.05% | 396M | |
-81.65% | 216M | |
-13.42% | 111M | |
-23.19% | 50.19M |
- Stock Market
- Equities
- NSIS B Stock
- News Novonesis A/S
- Novozymes A/S Announces Executive Appointments, Effective April 2021